Peer Mentorship for Type 1 Diabetes

Recruiting in Palo Alto (17 mi)

Age: < 18

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Nemours Children's Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this clinical trial is to evaluate a new way of helping adolescents with type 1 diabetes consistently use continuous glucose monitoring systems (CGM). Families who participate will be assigned by chance to one of two groups. One group will continue to see their Endocrinology provider who can give recommendations on ways to use CGM. The other group will be in our Type 1 Together program for 6 months. This will include: 1. Monthly meetings with a community health worker with expertise in type 1 diabetes self-management, 2. Access to CGM-specific educational resources hosted on a mobile app, and 3. Meeting at least monthly with a mentor family who will provide mentorship on using CGM consistently. The main questions the study aims to answer are: 1. Do families like the Type 1 Together program? 2. Do more families in the Type 1 Together program have better attitudes towards CGM, use CGM more consistently, and have lower HbA1c? 3. Does the Type 1 Together program reduce racial and ethnic differences in attitudes towards CGM, consistent use of CGM, and HbA1c?

Eligibility Criteria

This trial is for adolescents aged 12-17 with type 1 diabetes who haven't been using a continuous glucose monitoring system (CGM) regularly. They should be diagnosed for at least 6 months and able to read/write in English. It's not suitable for those with diabetes due to other conditions, intellectual disabilities, or severe psychiatric issues.

Inclusion Criteria

I am between 12 and 17 years old.

I have been diagnosed with type 1 diabetes for over 6 months.

Exclusion Criteria

I have type 1 diabetes caused by another condition like cystic fibrosis.

Participant Groups

The study compares standard care from an Endocrinology provider against the 'Type 1 Together' program which includes monthly meetings with health workers, educational resources on a mobile app, and mentorship from experienced families on CGM use over six months.

2Treatment groups

Experimental Treatment

Active Control

Group I: Type 1 TogetherExperimental Treatment1 Intervention

In Type 1 Together, families will work with other families who have experience using CGM (Peer Mentors) to overcome common barriers to CGM use. Families in the Type 1 Together program will also have access to CGM-specific educational materials, a digital journal to facilitate patient-provider communication around issues with CGM, and social determinant of health screening and intervention with a diabetes community health worker.

Group II: Standard of CareActive Control1 Intervention

Quarterly clinic visits with endocrinology provider.